These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 23735217)

  • 21. The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension.
    Roger I; Milara J; Montero P; Cortijo J
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JAK/STAT pathway and molecular mechanism in bone remodeling.
    Sanpaolo ER; Rotondo C; Cici D; Corrado A; Cantatore FP
    Mol Biol Rep; 2020 Nov; 47(11):9087-9096. PubMed ID: 33099760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics and non-canonical aspects of JAK/STAT signalling.
    Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
    Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canonical and non-canonical JAK/STAT transcriptional targets may be involved in distinct and overlapping cellular processes.
    Tsurumi A; Zhao C; Li WX
    BMC Genomics; 2017 Sep; 18(1):718. PubMed ID: 28893190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mining for JAK-STAT mutations in cancer.
    Constantinescu SN; Girardot M; Pecquet C
    Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
    Coskun M; Salem M; Pedersen J; Nielsen OH
    Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cucurbitacin E reduces obesity and related metabolic dysfunction in mice by targeting JAK-STAT5 signaling pathway.
    Murtaza M; Khan G; Aftab MF; Afridi SK; Ghaffar S; Ahmed A; Hafizur RM; Waraich RS
    PLoS One; 2017; 12(6):e0178910. PubMed ID: 28598969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance.
    Sabaawy HE; Ryan BM; Khiabanian H; Pine SR
    Carcinogenesis; 2021 Dec; 42(12):1411-1419. PubMed ID: 34415330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JAK-STAT Signaling and Beyond in the Pathogenesis of Spondyloarthritis and Their Clinical Significance.
    Raychaudhuri SP; Shah RJ; Banerjee S; Raychaudhuri SK
    Curr Rheumatol Rep; 2024 Jun; 26(6):204-213. PubMed ID: 38492148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JAK inhibition and progressive kidney disease.
    Brosius FC; He JC
    Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):88-95. PubMed ID: 25415616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JAK-STAT in lipid metabolism of adipocytes.
    Xu D; Yin C; Wang S; Xiao Y
    JAKSTAT; 2013 Oct; 2(4):e27203. PubMed ID: 24498541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells.
    Seif F; Khoshmirsafa M; Aazami H; Mohsenzadegan M; Sedighi G; Bahar M
    Cell Commun Signal; 2017 Jun; 15(1):23. PubMed ID: 28637459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications.
    Park H; Lee S; Lee J; Moon H; Ro SW
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JAK-STAT signaling in cancer: From cytokines to non-coding genome.
    Pencik J; Pham HT; Schmoellerl J; Javaheri T; Schlederer M; Culig Z; Merkel O; Moriggl R; Grebien F; Kenner L
    Cytokine; 2016 Nov; 87():26-36. PubMed ID: 27349799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.
    Zhao R; Hu Z; Zhang X; Huang S; Yu G; Wu Z; Yu W; Lu J; Ruan B
    Cell Commun Signal; 2024 Jan; 22(1):68. PubMed ID: 38273295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in mice.
    Kaltenecker D; Mueller KM; Benedikt P; Feiler U; Themanns M; Schlederer M; Kenner L; Schweiger M; Haemmerle G; Moriggl R
    Diabetologia; 2017 Feb; 60(2):296-305. PubMed ID: 27858140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy.
    Mahjoor M; Mahmoudvand G; Farokhi S; Shadab A; Kashfi M; Afkhami H
    Cell Commun Signal; 2023 Oct; 21(1):272. PubMed ID: 37784164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in Lung inflammatory disease.
    Purohit M; Gupta G; Afzal O; Altamimi ASA; Alzarea SI; Kazmi I; Almalki WH; Gulati M; Kaur IP; Singh SK; Dua K
    Chem Biol Interact; 2023 Feb; 371():110334. PubMed ID: 36610610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of JAK/STAT signaling pathway prevents high-glucose-induced increase in endothelin-1 synthesis in human endothelial cells.
    Manea SA; Manea A; Heltianu C
    Cell Tissue Res; 2010 Apr; 340(1):71-9. PubMed ID: 20217138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models.
    Moon SY; Kim KD; Yoo J; Lee JH; Hwangbo C
    Molecules; 2021 May; 26(9):. PubMed ID: 34068714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.